| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.084 | 0.003 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.18 | 0.004 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.68 | 0.005 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.099 | 0.006 |